Murphy et al. reported that the oncogenic transcription factor MYCN co-localizes with methyl-binding proteins, such as MeCP2 at hypermethylated DNA regions, highlighting the intricate relationship between transcription factors and DNA methylation in NB [46]. The gene discussed is MYCN; the disease is neuroblastoma.